166 related articles for article (PubMed ID: 24024027)
1. Manifestations of adipose tissue dysfunction.
Abate N; Sumner AE; Chandalia MS
J Obes; 2013; 2013():940275. PubMed ID: 24024027
[No Abstract] [Full Text] [Related]
2. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
3. 'Dysfunctional' adipose tissue in cardiovascular disease: a reprogrammable target or an innocent bystander?
Antoniades C
Cardiovasc Res; 2017 Jul; 113(9):997-998. PubMed ID: 28637258
[No Abstract] [Full Text] [Related]
4. Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases.
Belin de Chantemèle EJ
Adv Exp Med Biol; 2017; 1043():87-111. PubMed ID: 29224092
[TBL] [Abstract][Full Text] [Related]
5. The role of circadian clocks in metabolic disease.
Li MD; Li CM; Wang Z
Yale J Biol Med; 2012 Sep; 85(3):387-401. PubMed ID: 23012586
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue and the physiologic underpinnings of metabolic disease.
O'Rourke RW
Surg Obes Relat Dis; 2018 Nov; 14(11):1755-1763. PubMed ID: 30193906
[TBL] [Abstract][Full Text] [Related]
7. Ectopic fat and cardiovascular disease: what is the link?
Gastaldelli A; Basta G
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):481-90. PubMed ID: 20659791
[TBL] [Abstract][Full Text] [Related]
8. Emerging Roles for Adipose Tissue in Cardiovascular Disease.
Ha EE; Bauer RC
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):e137-e144. PubMed ID: 30354196
[No Abstract] [Full Text] [Related]
9. Exercise Metabolism.
Cell Metab; 2017 May; 25(5):978-984. PubMed ID: 28467940
[TBL] [Abstract][Full Text] [Related]
10. Point: Counterpoint synopsis of cardiometabolic risk after spinal cord injury.
Gater DR
Spinal Cord Ser Cases; 2019; 5():98. PubMed ID: 31798973
[No Abstract] [Full Text] [Related]
11. Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease.
Rafeh R; Viveiros A; Oudit GY; El-Yazbi AF
Clin Sci (Lond); 2020 Apr; 134(7):827-851. PubMed ID: 32271386
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and metabolic dysfunction: links to cardiovascular diseases.
Taube A; Schlich R; Sell H; Eckardt K; Eckel J
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2148-65. PubMed ID: 22447947
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and cardio-metabolic disease.
Vaidya A
Metabolism; 2013 Dec; 62(12):1697-9. PubMed ID: 24050269
[No Abstract] [Full Text] [Related]
14. The Role of Adipose Tissue Mitochondria: Regulation of Mitochondrial Function for the Treatment of Metabolic Diseases.
Lee JH; Park A; Oh KJ; Lee SC; Kim WK; Bae KH
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590292
[No Abstract] [Full Text] [Related]
15. Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease.
Meijer RI; Serne EH; Smulders YM; van Hinsbergh VW; Yudkin JS; Eringa EC
Curr Diab Rep; 2011 Jun; 11(3):211-7. PubMed ID: 21461998
[TBL] [Abstract][Full Text] [Related]
16. mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging.
Das A; Reis F; Maejima Y; Cai Z; Ren J
Oxid Med Cell Longev; 2017; 2017():6018675. PubMed ID: 28770023
[No Abstract] [Full Text] [Related]
17. Modulation of cardiovascular function by adipokines.
DeClercq V; Enns JE; Yeganeh A; Taylor CG; Zahradka P
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):59-72. PubMed ID: 22882074
[TBL] [Abstract][Full Text] [Related]
18. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
Schinzari F; Tesauro M; Cardillo C
J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
[TBL] [Abstract][Full Text] [Related]
19. Pathological role of adipose tissue dysfunction in cardio-metabolic disorders.
Shimizu I; Yoshida Y; Minamino T
Int Heart J; 2015 May; 56(3):255-9. PubMed ID: 25912906
[TBL] [Abstract][Full Text] [Related]
20. Effects of activation of endocannabinoid system on myocardial metabolism.
Polak A; Harasim E; Chabowski A
Postepy Hig Med Dosw (Online); 2016 May; 70(0):542-55. PubMed ID: 27333924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
